Explore the biggest pharma M&A deals of 2025—from biosimilars to CDMO takeovers—and what they mean for strategy, R&D, and supply chains.

Oct 10, 2025 · After a cautious Q2 amid FDA workforce changes and drug pricing policy debates, deal flow accelerated dramatically in Q3-Q4. September alone saw $8.7B in activity, with the …

Last month (July 2025), Merck KGaA completed its acquisition of SpringWorks Therapeutics, a Stamford, Connecticut-based commercial-stage bio/pharmaceutical company focused on …

Jan 31, 2024 · The global pharmaceutical industry witnesses an excess of merger and acquisition (M&A) activity every year—probably more than most other industries—both in the number of …

Jun 27, 2025 · Healthcare Brew wanted to break down the largest mergers, acquisitions, and buyouts so far this year. We worked with global market data research company PitchBook and …

Jun 18, 2025 · In the first half of 2025, pharmaceutical and life sciences (PLS) deal activity remained relatively steady but cautious, dominated largely by bespoke, strategic acquisitions in …

Senores Pharmaceuticals (SPI) has acquired a 51% stake in Zoraya Pharmaceuticals, marking an expansion in the U.S. market.

3 days ago · Many of today’s most lucrative medicines, from the life-saving cancer treatment Keytruda to the anti-inflammatory agent Enbrel, might not have become so without mergers …

Dec 2, 2025 · After a relatively modest 2024, where companies favored smaller, strategic deals over large-scale acquisitions, industry analysts are predicting major players to be bolder and …

Explore the top pharma mergers and acquisitions of 2024 driving innovation, growth, and transformative healthcare advancements. The worldwide pharmaceutical industry undergoes …